MediWound Germany
This sponsor has funded 2 studies across 2 countries.
| EU PAS ID | Status | RMP requirement | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|---|
| 21681 | Finalised | Not included in RMP | NEXOBRID Belgian registry: Prospective Assessment of Efficacy of NexoBrid in the treatment of Adult Patients with deep 2nd degree and 3rd degree... | No | Yes |
| 23046 | Finalised | Not included in RMP | A prospective, non-interventional multicenter study, performed in patients with burns, to evaluate efficacy and safety aspects of NexoBrid in clinical... | Yes | Yes |
PAS by Risk Management Plan (RMP) requirement
MediWound Germany
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
MediWound Germany
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
MediWound Germany
2 Study countries specified are the following:
- Belgium
- Germany